Finance

Beta
Lists
TLX:NASDAQ
Telix Pharmaceuticals American Depositary Shares
$9.43
-1.05%
(-0.100) 1D
May 29, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TLX...
Open
$9.46
High
$9.53
Low
$9.40
Mkt. cap
4.42B
Avg. vol.
138.60K
Volume
141.02K
52-wk high
$18.49
52-wk low
$6.28
Shares outstanding
339.38M
No. of employees
1K
Open
$9.46
High
$9.53
Low
$9.40
Mkt. cap
4.42B
Avg. vol.
138.60K
Volume
141.02K
52-wk high
$18.49
52-wk low
$6.28
Shares outstanding
339.38M
No. of employees
1K
News stories
From sources across the web
About Telix Pharmaceuticals American Depositary Shares
CEOChristian Behrenbruch
Employees1.15K
Founded2015
Headquarters-
SectorBiotechnology
Websitetelixpharma.com
Last report
Apr 6, 2026
Fiscal period
Q1 2026
EPS / Est. (AUD)
- / A$0.01
Revenue / Est. (AUD)
332.61M / 311.55M
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in AUD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
195.18M
195.18M
206.72M
206.72M
Cost of goods sold
100.29M
100.29M
110.68M
110.68M
Cost of revenue
100.29M
100.29M
110.68M
110.68M
Research and development expenses
40.79M
40.79M
44.83M
44.83M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
48.35M
48.35M
47.93M
47.93M
Operating expense
89.26M
89.26M
92.02M
92.02M
Total operating expenses
189.55M
189.55M
202.70M
202.70M
Operating income
5.62M
5.62M
4.02M
4.02M
Other non operating income
-6.32M
-6.32M
-7.23M
-7.23M
EBT including unusual items
-2.42M
-2.42M
-215.00K
-215.00K
EBT excluding unusual items
-1.41M
-1.41M
-6.75M
-6.75M
Income tax expense
-1.27M
-1.27M
2.20M
2.20M
Effective tax rate
52.61%
52.61%
-1,023.95%
-1,023.95%
Other operating expenses
122.50K
122.50K
-745.50K
-745.50K
Net income
-1.15M
-1.15M
-2.42M
-2.42M
Net profit margin
-0.59%
-0.59%
-1.17%
-1.17%
Earnings per share
-
-
-
-
Interest and investment income
1.81M
1.81M
1.10M
1.10M
Interest expense
-3.10M
-3.10M
-3.78M
-3.78M
Net interest expenses
-1.29M
-1.29M
-2.68M
-2.68M
Depreciation and amortization charges
-
-
-
-
EBITDA
9.14M
9.14M
7.09M
7.09M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer